PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma

Overexpression of PARP1 exists in various cancers, including glioblastoma (GBM). Although PARP1 inhibition is a promising therapeutic target, no comprehensive study has addressed PARP1's expression characteristics and prognostic role regarding molecular heterogeneity in astrocytomas including G...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Murnyák, Balázs, Kouhsari, Mahan C., Hershkovitch, Rotem, Kálmán, Bernadette, Marko-Varga, György, Klekner, Álmos, Hortobágyi, Tibor
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542272/
https://ncbi.nlm.nih.gov/pubmed/28654422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars